AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
Biosimilars market seen reaching $48.52 billion by 2030
AGP
The Business Research Company says the global biosimilars market will grow from $21.85 billion in 2025 to $25.53 billion in 2026, then nearly double to $48.52 billion by 2030. The report points to patent expirations, higher healthcare spending and…
Biguanides market to reach $5.97 billion by 2030
AGP
The global biguanides market is projected to grow from $5.11 billion in 2025 to $5.28 billion in 2026, as demand rises for diabetes and metabolic disorder treatments.
Space robotics market seen reaching $7.49 billion by 2030
AGP
The Business Research Company says the global space robotics market is set to grow from $5.55 billion in 2026 to $7.49 billion by 2030, driven by lunar and Mars missions, on-orbit servicing and AI-enabled autonomy.
Space security market seen hitting $34.7 billion by 2030
AGP
The Business Research Company says the global space security market is set to rise from $25.26 billion in 2026 to $34.7 billion by 2030, driven by geopolitical tensions, satellite protection needs and new space traffic management tools.
Biosimilar lymphocyte modulator market seen reaching $3.53 billion by 2030
AGP
The biosimilar lymphocyte modulator market is forecast to grow from $2.1 billion in 2025 to $3.53 billion by 2030, driven by patent expirations, more biosimilar development and rising demand for autoimmune and cancer therapies.
Biosimilar interleukins market seen reaching $41.22 billion by 2030
AGP
The Business Research Company says the global biosimilar interleukins market is on a steep growth path, rising from $7.52 billion in 2025 to a projected $41.22 billion by 2030. The expansion is being driven by higher autoimmune disease prevalence,…
Jewish National Fund-USA draws nearly 3,000 to San Diego conference on Israel's future
AGP
Jewish National Fund-USA brought nearly 3,000 supporters to San Diego from Nov. 12-15 for its 2026 Global Conference for Israel, spotlighting new investments in Israel’s North and South, youth leadership, and Zionist engagement.
Zostavax market forecast points to growth through 2035
AGP
The Business Research Company says the Zostavax vaccine market is set to expand as aging populations, higher shingles risk, and broader vaccine access lift demand.
YF-Vax market seen reaching $9.81 million by 2030 as travel demand rises
AGP
The YF-Vax market is projected to grow from $6.78 million in 2025 to $7.32 million in 2026, with demand boosted by international travel, vector-borne disease awareness and public health spending.
Bakuchiol market seen reaching $1.62 billion by 2030
AGP
The Business Research Company says the bakuchiol market is set to keep growing as clean beauty, organic ingredients and retinol alternatives gain traction.
Zymfentra market set for rapid growth through 2035
AGP
The Business Research Company says the Zymfentra market is entering a rapid-growth phase, driven by aging populations, higher healthcare spending and broader use of enzyme replacement therapy.
Zomacton market seen growing on personalized medicine and pediatric demand
AGP
The Business Research Company says the global Zomacton market is set for long-term growth through 2035, driven by personalized medicine, higher healthcare spending and a rising pediatric population.
Zorbtive, Serostim market seen growing on HIV cases and personalized care
AGP
The Business Research Company says the global Zorbtive and Serostim market is gaining momentum as HIV diagnoses rise and personalized medicine expands.
Biobetters market seen topping $121.61 billion by 2030
AGP
The global biobetters market is projected to grow from $75.29 billion in 2025 to $121.61 billion by 2030, according to The Business Research Company.
Space insurance market seen reaching $6.23 billion by 2030
AGP
The global space insurance market is forecast to keep growing as satellite launches, mega-constellations and more complex orbital missions expand insurers’ exposure.
Biosimilar monoclonal antibodies market seen reaching $14.58 billion by 2030
AGP
The biosimilar monoclonal antibodies market is projected to grow from $11.29 billion in 2026 to $14.58 billion by 2030, according to The Business Research Company.
In-orbit refueling market seen reaching $2.7 billion by 2030
AGP
The space in-orbit refueling market is projected to grow from $1.69 billion in 2026 to $2.7 billion by 2030 as satellite operators push for longer mission lives and lower replacement costs.
Spacecraft market seen reaching $8.91 billion by 2030
AGP
The global spacecraft market is projected to rise from $6.76 billion in 2025 to $7.15 billion in 2026, with growth continuing to $8.91 billion by 2030, according to The Business Research Company.
Tenivac market seen growing on adult boosters, government campaigns
AGP
The Business Research Company says the global Tenivac market will keep expanding through 2035, led by adult booster demand, government immunization programs and an aging population.
Bevacizumab biosimilars market to reach $2.42 billion by 2030
AGP
The global bevacizumab biosimilars market is projected to rise from $1.64 billion in 2025 to $1.77 billion in 2026, driven by cancer prevalence, patent expirations and demand for lower-cost biologics.
Sign up for:
The Middle East Political Observer
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.